178 related articles for article (PubMed ID: 33687905)
1. Anticancer Effects of Ginsenoside Rh2: A Systematic Review.
He XL; Xu XH; Shi JJ; Huang M; Wang Y; Chen X; Lu JJ
Curr Mol Pharmacol; 2022; 15(1):179-189. PubMed ID: 33687905
[TBL] [Abstract][Full Text] [Related]
2. Anticancer property of ginsenoside Rh2 from ginseng.
Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future.
Guan W; Qi W
Phytomedicine; 2023 Sep; 118():154938. PubMed ID: 37406390
[TBL] [Abstract][Full Text] [Related]
4. Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation.
Xiaodan S; Ying C
Biomed Pharmacother; 2022 Dec; 156():113912. PubMed ID: 36288668
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review).
Zhang H; Park S; Huang H; Kim E; Yi J; Choi SK; Ryoo Z; Kim M
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649861
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathway.
Huang J; Peng K; Wang L; Wen B; Zhou L; Luo T; Su M; Li J; Luo Z
Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):750-5. PubMed ID: 27177748
[TBL] [Abstract][Full Text] [Related]
7. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
Lv Q; Rong N; Liu LJ; Xu XL; Liu JT; Jin FX; Wang CM
Planta Med; 2016 May; 82(8):705-11. PubMed ID: 27163230
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
[TBL] [Abstract][Full Text] [Related]
9. Potential of ginsenoside Rh
Li K; Li Z; Men L; Li W; Gong X
Chin J Nat Med; 2022 Dec; 20(12):881-901. PubMed ID: 36549803
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats.
Lee WK; Kao ST; Liu IM; Cheng JT
Horm Metab Res; 2007 May; 39(5):347-54. PubMed ID: 17533576
[TBL] [Abstract][Full Text] [Related]
11. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
Zhang C; Yu H; Hou J
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
[TBL] [Abstract][Full Text] [Related]
12. AMP-activated protein kinase determines apoptotic sensitivity of cancer cells to ginsenoside-Rh2.
Kim MJ; Yun H; Kim DH; Kang I; Choe W; Kim SS; Ha J
J Ginseng Res; 2014 Jan; 38(1):16-21. PubMed ID: 24558305
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells.
Popovich DG; Kitts DD
J Biochem Mol Toxicol; 2004; 18(3):143-9. PubMed ID: 15252870
[TBL] [Abstract][Full Text] [Related]
14. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis.
Gao H; Liang D; Li C; Xu G; Jiang M; Li H; Yin J; Song Y
Biomed Pharmacother; 2020 Apr; 124():109891. PubMed ID: 31991384
[TBL] [Abstract][Full Text] [Related]
15. Rh2-enriched Korean ginseng (Ginseng Rh2+) inhibits tumor growth and development of metastasis of non-small cell lung cancer.
Lev-Ari S; Starr AN; Vexler A; Kalich-Philosoph L; Yoo HS; Kwon KR; Yadgar M; Bondar E; Bar-Shai A; Volovitz I; Schwarz Y
Food Funct; 2021 Sep; 12(17):8068-8077. PubMed ID: 34286798
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rh2 inhibits breast cancer cell growth via ERβ-TNFα pathway.
Peng K; Luo T; Li J; Huang J; Dong Z; Liu J; Pi C; Zou Z; Gu Q; Liu O; Zhang JT; Luo ZY
Acta Biochim Biophys Sin (Shanghai); 2022 May; 54(5):647-656. PubMed ID: 35593465
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models.
Bae EA; Han MJ; Shin YW; Kim DH
Biol Pharm Bull; 2006 Sep; 29(9):1862-7. PubMed ID: 16946499
[TBL] [Abstract][Full Text] [Related]
18. Production of Rare Ginsenosides Rg3 and Rh2 by Endophytic Bacteria from
Yan H; Jin H; Fu Y; Yin Z; Yin C
J Agric Food Chem; 2019 Aug; 67(31):8493-8499. PubMed ID: 31310523
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells.
Kitts DD; Popovich DG; Hu C
Can J Physiol Pharmacol; 2007 Nov; 85(11):1173-83. PubMed ID: 18066119
[TBL] [Abstract][Full Text] [Related]
20. Advances in Biocatalytic Synthesis, Pharmacological Activities, Pharmaceutical Preparation and Metabolism of Ginsenoside Rh2.
Liu L; Wang H; Chai X; Meng Q; Jiang S; Zhao F
Mini Rev Med Chem; 2022; 22(3):437-448. PubMed ID: 34517798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
